Innovation & Access: Healthcare’s New Battleground
We are on the frontline of transformative disruption with pharmaceutical drugs. Advances in science makes it possible to seek CURES for once intractable diseases. The policy developments in Washington have lasting implications on the ability of innovators to develop these opportunities, and for patients to benefit from them. What is the future of medical innovation? How can the healthcare industry successfully navigate the intersection of policy and medical innovation? More importantly, how does the healthcare sector EVOLVE as the landscape of benefit coverage and medical products change and new challenges emerge for consumers of health care and the employers who are financing the health care investment? Are there sustainable models for covering the cost of new innovations and modernize our payment models to make sure access to the medical care is guaranteed without bankrupting our healthcare system? What are the new models for healthcare delivery that we will need to embrace? Let’s hear from the person closest to this convergence: Former FDA Commissioner, Scott Gottlieb.